The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
It has been documented that statin reduce mortality and morbidity in patients with
cardiovascular disease. This effect can partly be related to a reduction in cholesterol
levels in blood. Nitric oxide (NO) production is reduced in several chronic diseases such as
nephropathy, diabetes and hypertension. The purpose of this study is to investigate the
effect of Atorvastatin treatment on the NO-system measuring renal and cardiovascular
variables in patients witk chronic kidney disease.